Molecular Insights into Bacterial Pathogenesis: Understanding Mechanisms and Developing Therapies
DOI:
https://doi.org/10.59675/P227Keywords:
Molecular Insights, Bacterial Pathogenesis, Developing Therapies.Abstract
Global public health continues to be among the very substantial challenges of bacterial infections, which are compounded by the emergence of antibiotic-resistant strains. This work is aimed at verifying the effectiveness of molecularly targeted anti-bacterial agents in reducing bacterial adhesion, invasion, cytotoxicity, and intracellular survival with a few examples of major pathogenic bacteria, including Escherichia coli (UPEC), Staphylococcus aureus (MRSA), Salmonella enterica and Mycobacterium tuberculosis using different molecular techniques like PCR to assess the impact of these anti-pathogenic processes. The disease severity scores were significantly reduced after treatment in all experimental groups as compared to control groups: E. coli (4.5 to 1.2), S. aureus (4.2 to 1.4), S. enterica (3.8 to 1.5) and M. tuberculosis (4.7 to 1.6). Decreases in bacterial adhesion and invasion were significant for E. coli and cytotoxicity for S aureus. In contrast, intracellular survival was decreased for both S enterica and M tuberculosis because of the treatment. Lower bacterial counts and virulence gene expression were less in the treatment groups, as seen from qPCR analysis, implying that molecular targeting was effective. These results underscore the capacity of combining molecular strategies with targeted treatments towards bacterial infections. Such a promising approach was unveiled to address the woes entangled around antibiotic resistance that leads to loss in clinical cases. Optimization of these duals should be taken on board in future investigations with a broader scope in mind, both at the bacteriological level and clinically speaking, having such applications explored within broader contexts.
References
Finlay, B. B., & Falkow, S. (1997). Common themes in microbial pathogenicity revisited. Microbiology and Molecular Biology Reviews, 61(2), 136-169.
Dixon, B. (2001). The power of biofilms. Microbiology Today, 28, 54-57.
Hentzer, M., et al. (2003). Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors. The EMBO Journal, 22(15), 3803-3815.
Ribet, D., & Cossart, P. (2015). How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes and Infection, 17(3), 173-183.
Bhavsar, A. P., Guttman, J. A., & Finlay, B. B. (2007). Manipulation of host-cell pathways by bacterial pathogens. Nature, 449(7164), 827-834.
Cornelis, G. R. (2006). The type III secretion injectisome, a complex nanomachine for intracellular ‘toxin’ delivery. Biological Chemistry, 387(8), 879-885.
Cossart, P., & Sansonetti, P. J. (2004). Bacterial invasion: The paradigms of enteroinvasive pathogens. Science, 304(5668), 242-248.
Galan, J. E., & Collmer, A. (1999). Type III secretion machines: Bacterial devices for protein delivery into host cells. Science, 284(5418), 1322-1328.
Finlay, B. B., & McFadden, G. (2006). Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell, 124(4), 767-782.
Buttner, D. (2012). Protein export according to schedule: Architecture, assembly, and regulation of type III secretion systems from plant- and animal-pathogenic bacteria. Microbiology and Molecular Biology Reviews, 76(2), 262-310.
Grant, A. J., et al. (2008). Modelling within-host spatiotemporal dynamics of invasive bacterial disease. PLOS Biology, 6(4), e74.
Haglund, C. M., & Welch, M. D. (2011). Pathogens and polymers: Microbe-host interactions illuminate the cytoskeleton. The Journal of Cell Biology, 195(1), 7-17.
Hornef, M. W., et al. (2002). Bacterial strategies for overcoming host innate and adaptive immune responses. Nature Immunology, 3(11), 1033-1040.
Isberg, R. R., et al. (2009). Host cell signaling and the bacterial cytoskeleton: Evidence for crosstalk and novel mechanisms of regulation. Current Opinion in Microbiology, 12(1), 40-45.
Knodler, L. A., & Steele-Mortimer, O. (2005). The Salmonella effector PipB2 affects late endosome/lysosome distribution to mediate Sif extension. Molecular Biology of the Cell, 16(9), 4108-4123.
Ribet, D., & Cossart, P. (2015). How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes and Infection, 17(3), 173-183.
Sauer, J. D., et al. (2010). Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host & Microbe, 7(5), 412-419.
Schesser, K., et al. (1996). The Yersinia Yop virulon: A bacterial system for subverting eukaryotic cell signalling. Molecular Microbiology, 20(3), 401-415.
Shi, Y., et al. (2004). Structure of the ectodomain of the type III secretion system needle protein from Shigella flexneri. Nature Structural & Molecular Biology, 13(9), 762-767.
Stebbins, C. E., & Galan, J. E. (2001). Structural mimicry in bacterial virulence. Nature, 412(6848), 701-705.
van der Woude, M. W., & Baumler, A. J. (2004). Phase and antigenic variation in bacteria. Clinical Microbiology Reviews, 17(3), 581-611.
Viala, J., et al. (2004). Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nature Immunology, 5(11), 1166-1174.
Weiss, D. S. (2004). Bacterial cell division and the septal ring. Molecular Microbiology, 54(3), 588-597.
Wu, S., et al. (2010). Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells. Cell Host & Microbe, 7(5), 481-492.
Zhou, D., & Galan, J. (2001). Salmonella entry into host cells: The work in concert of type III secreted effector proteins. Microbes and Infection, 3(14-15), 1293-1298.
Finlay, B. B., & Cossart, P. (1997). Exploitation of mammalian host cell functions by bacterial pathogens. Science, 276(5313), 718-725.
Grassl, G. A., & Finlay, B. B. (2008). Pathogenesis of enteric Salmonella infections. Current Opinion in Gastroenterology, 24(1), 22-26.
Heesemann, J., & Laufs, R. (1985). Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. Journal of Clinical Microbiology, 22(1), 168-175.
Ireton, K. (2013). Molecular mechanisms of cell-cell spread of intracellular bacterial pathogens. Open Biology, 3(3), 130079.
Mukherjee, S., et al. (2006). Antibacterial toxin delivery by the contact-dependent type VI secretion system of Pseudomonas aeruginosa. Proceedings of the National Academy of Sciences, 103(50), 18849-18854.
Brodsky, I. E., & Medzhitov, R. (2009). Targeting of immune signalling networks by bacterial pathogens. Nature Cell Biology, 11(5), 521-526.
Gal-Mor, O., Boyle, E. C., & Grassl, G. A. (2014). Same species, different diseases: How and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Frontiers in Microbiology, 5, 391.
He, S. Y., Nomura, K., & Whittam, T. S. (2004). Type III protein secretion mechanism in mammalian and plant pathogens. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1694(1-3), 181-206.
Rosenberg, E., DeLong, E. F., Lory, S., Stackebrandt, E., & Thompson, F. (2013). The Prokaryotes: Pathogenic Bacteria. Springer Science & Business Media.
Schwiesow, L., et al. (2015). Common Modulators of Pathogen-Triggered Host Cell Reprogramming: Lessons from Two Model Bacterial Pathogens. Microbiology Spectrum, 3(6), doi:10.1128/microbiolspec.MBP-0011-2014.
Stanley, P., & Koronakis, V. (2003). Enteropathogenic E. coli secretes effector proteins via a type III secretion system for rapid, efficient modulation of host cell biology. FEMS Microbiology Letters, 223(1), 1-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Academic International Journal of Pure Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
